Franklin Street Advisors’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$625K	Hold	11,300	–	–	0.04%	101
2025 Q1	$546K	Hold	11,300	–	–	0.04%	104
2024 Q4	$436K	Sell	11,300 -100	-0.9%	-$3.86K	0.03%	117
2024 Q3	$513K	Sell	11,400 -70	-0.6%	-$3.15K	0.03%	107
2024 Q2	$397K	Hold	11,470	–	–	0.03%	118
2024 Q1	$332K	Sell	11,470 -250	-2%	-$7.24K	0.02%	130
2023 Q4	$269K	Hold	11,720	–	–	0.02%	130
2023 Q3	$195K	Sell	11,720 -500	-4%	-$8.32K	0.02%	144
2023 Q2	$338K	Hold	12,220	–	–	0.03%	114
2023 Q1	$281K	Sell	12,220 -30,000	-71%	-$690K	0.03%	120
2022 Q4	$461K	Hold	42,220	–	–	0.04%	95
2022 Q3	$356K	Hold	42,220	–	–	0.04%	107
2022 Q2	$334K	Buy	42,220 +20,000	+90%	+$158K	0.03%	117
2022 Q1	$526K	Hold	22,220	–	–	0.04%	105
2021 Q4	$760K	Hold	22,220	–	–	0.06%	95
2021 Q3	$394K	Buy	22,220 +1,970	+10%	+$34.9K	0.03%	118
2021 Q2	$909K	Sell	20,250 -2,000	-9%	-$89.8K	0.08%	83
2021 Q1	$576K	Hold	22,250	–	–	0.05%	104
2020 Q4	$449K	Hold	22,250	–	–	0.04%	109
2020 Q3	$435K	Sell	22,250 -1,050	-5%	-$20.5K	0.05%	103
2020 Q2	$411K	Sell	23,300 -200	-0.9%	-$3.53K	0.05%	99
2020 Q1	$166K	Hold	23,500	–	–	0.02%	126
2019 Q4	$166K	Hold	23,500	–	–	0.02%	148
2019 Q3	$282K	Hold	23,500	–	–	0.04%	128
2019 Q2	$285K	Hold	23,500	–	–	0.04%	126
2019 Q1	$295K	Hold	23,500	–	–	0.04%	123
2018 Q4	$158K	Sell	23,500 -3,500	-13%	-$23.5K	0.03%	135
2018 Q3	$278K	Sell	27,000 -300	-1%	-$3.09K	0.04%	131
2018 Q2	$183K	Sell	27,300 -19,400	-42%	-$130K	0.03%	150
2018 Q1	$401K	Hold	46,700	–	–	0.06%	110
2017 Q4	$971K	Buy	46,700 +30,000	+180%	+$624K	0.15%	87
2017 Q3	$295K	Buy	+16,700	New	+$295K	0.05%	121